Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 5/20 | 0.46 |
| ▸ | MAOB | P27338 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10576015 | 0.89 | THRB (0.49) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL27659642 | 0.86 | THRB (0.57) | ALDH1A1ACHETHRBLMNAL3MBTL1 | |
| SCHEMBL7381752 | 0.84 | CA12 (0.50) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL4817978 | 0.81 | NR3C1 (0.46) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL5704167 | 0.81 | CA12 (0.63) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL18844813 | 0.81 | TAAR1 (0.52) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL10899332 | 0.81 | ALDH1A1 (0.45) | ALDH1A1THRBLMNAL3MBTL1KMT2A | |
| SCHEMBL31725844 | 0.79 | CA12 (0.53) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL19543259 | 0.79 | NQO1 (0.64) | CA12CA2CA9GSTP1CA1 | |
| SCHEMBL16845306 | 0.79 | ADAM17 (0.46) | ALDH1A1THRBLMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109096212-A | A kind of method of water phase one pot process 5-I-1,2,3- triazole compound | 河南师范大学 | 2018-12-28 | — | — | CN | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-9212381-B2 | Methods and compositions for labeling polypeptides | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-12-15 | — | — | US | disclosed |
| US-20130122535-A1 | METHODS AND COMPOSITIONS FOR LABELING POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-05-16 | — | — | US | disclosed |
| EP-0333445-B1 | Aromatic allene compounds and preparation thereof | NIPPON PAINT CO LTD (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5340931-A | Chemical intermediates for allyl or vinyl ether polymers | NIPPON PAINT CO., LTD. (JP) | 1994-08-23 | — | — | US | disclosed |
| EP-0333445-A2 | Aromatic allene compounds and preparation thereof | NIPPON PAINT CO., LTD. (JP) | 1989-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | CA12 2348/4885CA2 4828/4885CA9 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.